Rankings
▼
Calendar
VTRS FY 2014 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena
VTRS
Viatris Inc.
$16B
FY 2014 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$7.7B
+11.7% YoY
Gross Profit
$3.5B
45.7% margin
Operating Income
$1.4B
17.5% margin
Net Income
$929M
12.0% margin
EPS (Diluted)
$2.34
Cash Flow
Operating Cash Flow
$1.0B
Free Cash Flow
$690M
Stock-Based Comp.
$66M
Balance Sheet
Total Assets
$15.8B
Total Liabilities
$12.5B
Stockholders' Equity
$3.3B
Cash & Equivalents
$226M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7.7B
$6.9B
+11.7%
Gross Profit
$3.5B
$3.0B
+16.0%
Operating Income
$1.4B
$1.1B
+19.1%
Net Income
$929M
$624M
+49.0%
← FY 2013
All Quarters
FY 2015 →